HOME ZACKS RESEARCH PORTFOLIO COMMUNITY BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank     Equity Research     My Account     Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login
Search:

 Related Links
Zacks Equity Research
Reports: All Premium Content
Reports: Buys Premium Content
By Industry Premium Content
Upgrades Premium Content
Downgrades Premium Content
Bull of the Day
Bear of the Day
Industry Outlook
Analyst Blog
Performance
About Zacks Equity Research

Subscription Services
Product Guide
Value Trader 2
Zacks Premium
Zacks Elite
Method for Trading
Breakout Trader
Champion Trader
Chart Patterns Trader
Growth Trader
Momentum Trader
Options Trader
Surprise Trader
Value Trader
Partner Newsletters
Special Reports
Top 10 Stocks
Research Wizard

Zacks Commentary: Zacks Analyst Interviews

  PRINTABLE VERSION  
Revisions Ratios Uncover Hidden Gems
With Dirk Van Dijk
Aug 22, 2008
Our Director of Zacks Equity Research Dirk van Dijk, CFA slices and dices all sorts of data on publicly traded industries. Recently, we got his take on something called a “revisions ratio,” and managed to get a few Buy recommendations in the process.

You track something called a “revisions ratio.” Could you tell us a little about it?

To help gauge the direction of the market, we take note of what analysts are thinking. By tallying their EPS changes, we can determine our “revisions ratio.” This ratio simply divides the total number of positive estimate revisions by the total number of estimate cuts. Thus, a high ratio is a bullish indicator and a low ratio is bearish. For the S&P 500 as a whole, a number below 0.80 or above 1.25 is generally significant. For individual sectors the distance from 1.0 should be greater for the numbers to be significant.

And how have performances been in the quarter just reported?

With positive surprises outnumbering disappointments by almost five to two, it is not a shock that the revisions ratio has started to climb from the depths. After all, second-quarter earnings are part of full-year 2008 earnings, so if a company posts a positive surprise and the analysts don’t raise full-year earnings, they are implicitly cutting estimates for the third or fourth quarters.

It is now at 1.08, a reading that is neutral, up from 1.05 last week, and 0.98 two weeks ago. The overall pace of estimate revisions continues its rise, and is approaching its seasonal peak. Over the last four weeks there have been 3,727 changes in estimates: 1,939 up and 1,788 down, up 3.5% from 3,600: 1,841 up and 1,759 down last week. This week or next should mark the peak of total revisions activity for the quarter. The ratio of firms with rising mean estimates to falling mean estimates is 1.02, slightly weaker than the revisions ratio, but also in neutral territory.

According to the revisions ratio, which industries performed best?

On the back of their strong surprise ratios, Health Care and Industrials have moved into the top slots for the 2008 revisions ratio, with readings of 2.94 and 2.57, respectively. Surprises have not been as strong for Energy (2.4:1 ratio, 2.65% median surprise), but it still has a respectable reading of 1.26. Still, this is way down from where it was a month or two ago, as lower oil prices work their way into analysts forecasts for this year.

Financials and Discretionary are the weak sisters with readings of 0.53 and 0.74, respectively. However, these readings represent a significant improvement over what we were seeing before earnings season.

Which specific companies look to benefit from this?

Notable Health Care stocks on the upside include Johnson & Johnson (JNJ), St. Jude (STJ) and Wyeth (WYE). The Aerospace and Defense names were particularly strong among the Industrials, including General Dynamics (GD), Lockheed Martin (LMT) and Honeywell (HON).

And where should investors stay wary?

In the Consumer Discretionary sector, the analysts slammed the brakes on the Auto companies Ford (F) and General Motors (GM). In the Financials, many of the regional banks continue to get hit, with noteworthy declines in National City (NCC), Regions Financial (RF), Washington Mutual (WM) and Zion (ZION).

Dirk van Dijk, CFA is the Director of Zacks Equity Research.

       Email        Feedback          Print       


About Zacks Analyst Interviews

Zacks Equity Research employs 50 stock analysts who are experts in the industries they cover. In these articles you will discover our analyst's insights on key industries in the news along with their favorite stocks to buy and sell now.

Zacks Equity Research Home Page

ZACKS COMMENTARY: ZACKS ANALYST INTERVIEWS ARCHIVE

Machinery/Industrials
With Mario Ricchio
Nov 20, 2008
Our outlook for the machinery sector is increasingly one of caution. We are beginning to see U.S economic weakness and the credit crunch negatively impact international markets. We discuss SNP, FCX and CAT.

Retail Industry
With Rob Plaza
Nov 19, 2008
Despite the apparent values in retail stocks, there are few reasons to get excited about the retailers. Consumer spending will remain subdued for the next few quarters, and that will lead to retailers' earnings estimates declining for the next several months. We recommend Kroger and PetMed Express.

Auto & Auto Parts
With Paul Raman
Nov 18, 2008
There is a focus on automation and simplifying product lines to lower costs and benefit from economies of scale. Earnings are below expectations and have been for some time. We look at GM, F, AXL, TRW and AN.

E&C/Aerospace/Defense
With John Nelson Simon
Nov 17, 2008
It's a historical reality that, after every major skirmish since WWII, the country's direction with respect to defense spending has been altered. Whatever the new path might be, it will take time to figure it all out. We look at BA and URS.

A Pep Talk for the Market-Weary
With Charles Rotblut
Nov 13, 2008
The markets will recover. It's just a matter of when, not if. We are bullish on Axsys Technologies, Bristol-Myers Squibb and PetMed Express.


 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2008 Zacks Investment Research